Penn Medicine Penn Hypertension, Insulin Resistance, Lipid, and Atherosclerosis Meeting 2025

• Target Audience: cardiologists, endocrinologists, internists, and primary care providers
• Sample video: contact me for sample video
• Information:

CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new therapeutic strategies for hypertension, hyperlipidemia, and CKD.

Learning Objectives

After completing this activity, participants should be able to:

Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations

Identify appropriate blood pressure treatment strategies in high-risk patient populations

Provide the best screening options for hypertension

Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention

• Topics:

Friday, September 19, 2025

SESSION I: HYPERTENSION UPDATES

SESSION II: PREVENTIVE CARDIOLOGY – UNDERSTANDING RISK AND EVALUATION

SESSION III: POTASSIUM AND HYPERTENSION

SESSION IV: NOVEL THERAPIES AND INDICATIONS